HPV18 E6 Antibodies

Santa Cruz Biotechnology features a diverse variety of HPV18 E6 monoclonal antibodies for investigating the role of E6 protein in human papillomavirus type 18 (HPV18) infection. HPV18 E6 Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The HPV18 E6 protein plays a significant role in the viral life cycle and interferes with host cell regulatory mechanisms, leading to oncogenic transformation. By promoting the degradation of tumor suppressor proteins such as p53, HPV18 E6 contributes to the development of cervical and other anogenital cancers. Understanding the function of HPV18 E6 is essential for developing targeted therapies and improving diagnostic methods for HPV-related malignancies. Research utilizing HPV18 E6 monoclonal antibodies has revealed important insights into viral mechanisms and cellular interactions. Ongoing studies continue to uncover new aspects of HPV18 E6 functionality and its impact on cell cycle regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of HPV-associated diseases and developing potential therapeutic strategies.